Used as a key intermediate in the synthesis of kinase inhibitors, particularly in the development of anticancer agents. Its structure enables selective binding to ATP sites in protein kinases, making it valuable in targeted therapies for cancers such as leukemia and non-small cell lung cancer. Also employed in research for inflammatory diseases due to its modulation of signaling pathways like JAK/STAT. Shows promise in improving drug potency and selectivity when incorporated into larger pharmacophores.